confronto caso- controllo fra chirurgia open ed endovascolare · vascular and endovascular surgery...

19
Vascular and Endovascular Surgery Unit- University of Florence CONFRONTO CASO - CONTROLLO FRA CHIRURGIA OPEN ED ENDOVASCOLARE DELL’ANEURISMA DELL’ARTERIA POPLITEA S. Speziali E. Giacomelli, A. Alessi Innocenti, A. Fargion, W. Dorigo, C. Lasagni, B. Giannasio, E. Chiti, C. Pratesi

Upload: lehanh

Post on 28-Feb-2019

216 views

Category:

Documents


0 download

TRANSCRIPT

Vascular and Endovascular Surgery Unit- University of Florence

CONFRONTO CASO-CONTROLLO FRA CHIRURGIA OPEN ED ENDOVASCOLARE

DELL’ANEURISMA DELL’ARTERIA POPLITEA

S. SpezialiE. Giacomelli, A. Alessi Innocenti, A. Fargion,W. Dorigo, C. Lasagni, B. Giannasio, E. Chiti,

C. Pratesi

Vascular and Endovascular Surgery Unit- University of Florence

(2008)

Vascular and Endovascular Surgery Unit- University of Florence

(J Vasc Surg 2015)

Vascular and Endovascular Surgery Unit- University of Florence

Vascular and Endovascular Surgery Unit- University of Florence

(Eur J Vasc Endovasc Surg, 2014)

Vascular and Endovascular Surgery Unit- University of Florence

(Ann Vasc Surg, 2010)

Vascular and Endovascular Surgery Unit- University of Florence

(J Vasc Surg 2017)

Vascular and Endovascular Surgery Unit- University of Florence

(Eur J Vasc Endovasc Surg, 2013)

Vascular and Endovascular Surgery Unit- University of Florence(Joshi et al., 2014)

Vascular and Endovascular Surgery Unit- University of Florence

CHIRURGIA OPEN vs ENDOVASCOLARE

STUDIO CASO – CONTROLLO “EXACT

MATCHING”

SCOPO DELLO

STUDIO

Vascular and Endovascular Surgery Unit- University of Florence

1981-2015, 309 interventi PAA

MATERIALI E

METODI

Vascular and Endovascular Surgery Unit- University of Florence

MATERIALI E

METODI

59

250OPEN vs ENDO

Endovascular Repair Open Repair

POPOLAZIONI EQUIVALENTI: 56 ENDOVASCULAR REPAIR Vs 56 OPEN REPAIR

Vascular and Endovascular Surgery Unit- University of Florence

OR (56) ER (56) p

Sesso M 55 (98%) 56 (100%) 0.8

Età 71.6±10.3 74.1±7.1 0.06

CAD 23 (41%) 20 (36%) 0.3

BPCO 26 (46%) 22 (39%) 0.4

Diabete 7 (12.5%) 4 (7%) 0.3

Ipertensione 49 (87%) 49 (87%) 1

Dislipidemia 25 (45%) 22 (39%) 0.5

CARATTERISTICHE DEL GRUPPO DI

STUDIO

Demografiche, Fattori di rischio e Comorbidità

Vascular and Endovascular Surgery Unit- University of Florence

OR (56) ER (56) p

Asintomatici PAA 38 (68%) 38 (68%) 1

Sintomatici PAA 18 (32%) 18 (32%) 1

Ischemia acuta 5 (9%) 8 (14%) 0.3

Trombosati PAA 9 (16%) 9 (16%) 1

Trombolisi preoperatoria 3 (6%) 8 (14%) 0.1

Run off distale < 2 vasi 11 (20%) 11 (20%) 1

Diametro PAA (mm) 32.5±11.2 32.9±12.7 0.9

CARATTERISTICHE DEL GRUPPO DI

STUDIO

Cliniche e Anatomiche

Vascular and Endovascular Surgery Unit- University of Florence

RISULTATI

PERIOPERATORI

OR (56) ER (56) p

Mortalità - 1 (1.7%) 0.3

Trombosi 4 (7%) 2 (3.5%) 0.4

Amputazione 2 (3.5%) - 0.1

Reintervento 3 (5%) 3 (5%) 0.7

Degenza media (gg) 5.7 ± 3.3 3.2 ± 1.1 <0.001

Vascular and Endovascular Surgery Unit- University of Florence

FOLLOW UP MEDIO: 53 mesi (range, 1-312- FU index 65%)

71 mesi OR Vs 36 mesi ER; p <0.001)

P=0.9, log rank 0.01; SE 0.07, 0.08 @ 4 yrs.P=0.4, log rank 0.6; SE 0.06, 0.08 @ 4 yrs.

Months

RISULTATI

TARDIVI

Vascular and Endovascular Surgery Unit- University of Florence

P=0.3, log rank 1.1; SE 0.07, 0.08 @ 4 yrs.P=0.9, log rank 0.01; SE 0.07, 0.08 @ 4 yrs.

RISULTATI

TARDIVI

Vascular and Endovascular Surgery Unit- University of Florence

Reinterventi OR (56) ER (56) p

OR per trombosi 7 (12.5%) 6 (10.7%) 0.3

OR non per trombosi*

1 (1.7%) - 0.4

Trombolisi

e ER2 (3.5%) 8 (14.3%) 0.04

ER non per trombosi**

- 2 (3.5%) 0.2

Overall 10 (17.8%) 16 (28.6%) 0.06

* Pseudoaneurismi anastomotici e progressione aneurismatica distale

** Endoleak tipo II 62.5%70%

RISULTATI

TARDIVI

Vascular and Endovascular Surgery Unit- University of Florence

• Nella nostra esperienza OR e ER mostrano similirisultati perioperatori e a lungo termine in gruppiequivalenti di pazienti.

• Maggior rischio di reintervento nei pazienti con trattamento endovascolare, ma risolvibili per la gran parte con mininvasità.

• Scelta della strategia terapeutica sul paziente.

CONCLUSIONI